← Back to guidelines
General Surgery4 papers

Chronic maxillary sinusitis

Last edited: 1 h ago

Overview

Chronic maxillary sinusitis (CMS) is a persistent inflammation of the maxillary sinus lasting more than 12 weeks, often presenting with unilateral symptoms such as facial pain, nasal congestion, and purulent discharge. It significantly impacts quality of life and can be challenging to treat, particularly when originating from dental sources or associated with anatomical abnormalities like nasal septal deviation. Given its multifaceted etiology, accurate diagnosis and tailored management are crucial in clinical practice to prevent chronic morbidity and improve patient outcomes.

Pathophysiology

Chronic maxillary sinusitis arises from a complex interplay of factors including persistent infection, impaired mucociliary clearance, and anatomical obstructions. In cases originating from dental sources, such as post-implant complications or pre-prosthetic procedures, bacteria from the oral cavity can migrate into the maxillary sinus, leading to chronic inflammation 1. The maxillary sinus's close anatomical relationship with the nasal cavity, particularly its connection to the ostiomeatal complex (OMC), exacerbates these issues when there is obstruction or deviation, such as septal deviation, which can impede normal drainage and ventilation 13. Histologically, chronic inflammation manifests through various patterns including lymphoplasmocytic, eosinophilic, and mixed infiltrates, reflecting the immune response to persistent antigenic stimuli 4. These cellular changes contribute to mucosal thickening and the formation of polyps, further complicating sinus drainage and exacerbating symptoms.

Epidemiology

Chronic maxillary sinusitis affects a broad demographic but is more prevalent in adults, with a mean age of 55 years as observed in a retrospective study 1. Males appear slightly more affected, with a male-to-female ratio of approximately 1.3:1 in some series. The condition is not uniformly distributed geographically but can be influenced by environmental factors such as pollution and climate. Recent trends suggest an increase in cases related to dental interventions, highlighting the evolving nature of its etiology 1. While precise incidence and prevalence figures vary, chronic sinusitis, including CMS, is estimated to affect up to 12% of the population, with dental origins accounting for a significant subset of unilateral cases 1.

Clinical Presentation

Patients with chronic maxillary sinusitis typically present with unilateral symptoms including facial pain or pressure, nasal congestion, purulent nasal discharge, and sometimes dental pain if the origin is dental 1. Middle meatus edema and pus in the middle meatus are common endoscopic findings, alongside nasal secretion and, less frequently, nasal polyposis 1. Red-flag features include severe unilateral facial swelling, fever, and signs of systemic infection, which may indicate complications such as orbital or intracranial extension 4. Chronic facial pain, often misattributed to sinusitis, can also manifest without typical sinus imaging abnormalities, suggesting a neurological origin in some cases 2.

Diagnosis

The diagnostic approach for chronic maxillary sinusitis involves a combination of clinical history, physical examination, and imaging studies. Key steps include:

  • Clinical History: Detailed inquiry into symptoms, dental history, and any recent dental procedures.
  • Physical Examination: Focus on nasal endoscopy to identify middle meatus edema, purulent discharge, and mucosal changes.
  • Imaging: CT scans of the sinuses are essential for visualizing anatomical abnormalities like septal deviation and assessing the extent of sinus involvement.
  • Specific Criteria and Tests:

  • Endoscopic Findings: Middle meatus edema (≥72%), pus in the middle meatus (≥70%), nasal secretion (≥39%) 1.
  • Imaging Criteria: Presence of opacification or fluid levels in the maxillary sinus on CT scan.
  • Laboratory Tests: Nasal cultures if purulence is present, though not always diagnostic due to polymicrobial nature.
  • Differential Diagnosis: Exclude conditions like dental abscess, migraine, and other causes of facial pain through targeted history and examination 2.
  • Differential Diagnosis

  • Dental Abscess: Often presents with localized dental pain and swelling, distinguished by clinical examination and imaging focusing on the oral cavity.
  • Facial Migraine: Characterized by episodic pain patterns and associated with triggers like stress or hormonal changes, differentiated by headache history and response to migraine-specific treatments 2.
  • Nasal Polyps: Typically bilateral and associated with more generalized nasal symptoms; confirmed by endoscopic visualization and histopathological examination 4.
  • Management

    First-Line Treatment

  • Medical Management:
  • - Antibiotics: Narrow-spectrum antibiotics if there is evidence of bacterial infection (e.g., amoxicillin-clavulanate 875 mg/125 mg twice daily for 10-14 days) 1. - Decongestants and Steroids: Nasal corticosteroids (e.g., fluticasone 50 mcg bid) and short-term oral decongestants (e.g., pseudoephedrine 60 mg tid) to reduce mucosal swelling and inflammation 1. - Antihistamines: For patients with allergic components (e.g., cetirizine 10 mg daily) 4.

    Second-Line Treatment

  • Endoscopic Sinus Surgery:
  • - Functional Endoscopic Sinus Surgery (FESS): Indicated for persistent symptoms despite medical therapy, focusing on clearing anatomical obstructions like septal deviation and opening the OMC 13. - Surgical Techniques: Utilize local mucoperiosteal flaps or buccal fat pad flaps for closure to prevent recurrence 1.

    Refractory Cases / Specialist Escalation

  • Advanced Surgical Interventions:
  • - Balloon Sinuplasty: Minimally invasive option for select patients with anatomical limitations 3. - Referral to Rhinology Specialist: For complex cases involving multiple sinuses or refractory symptoms, specialist evaluation and tailored surgical approaches are recommended 3.

    Contraindications:

  • Severe uncontrolled comorbidities (e.g., uncontrolled diabetes, immunosuppression).
  • Active infections requiring systemic antibiotics before surgical intervention.
  • Complications

  • Acute Complications: Orbital cellulitis, intracranial extension, and abscess formation, often necessitating urgent surgical intervention and hospitalization.
  • Long-Term Complications: Chronic pain syndromes, persistent nasal obstruction, and recurrent sinusitis, which may require ongoing management and periodic reassessment 4.
  • Prognosis & Follow-Up

    The prognosis for chronic maxillary sinusitis varies, with successful outcomes often dependent on early and accurate diagnosis and appropriate management. Key prognostic indicators include the presence of underlying dental issues, anatomical abnormalities, and response to initial medical therapy. Recommended follow-up intervals typically include:
  • Initial Follow-Up: 4-6 weeks post-treatment to assess response to medical therapy or surgical outcomes.
  • Long-Term Monitoring: Every 6-12 months to evaluate symptom resolution and prevent recurrence, especially in patients with predisposing factors 14.
  • Special Populations

  • Pediatrics: Diagnosis and management require careful consideration of growth and development, often favoring conservative approaches initially 1.
  • Elderly: Increased risk of comorbidities and potential drug interactions necessitate individualized treatment plans, possibly favoring less invasive interventions 1.
  • Post-Dental Procedures: Patients with recent dental implants or surgeries require heightened vigilance for signs of sinus involvement, emphasizing early intervention 1.
  • Key Recommendations

  • Diagnose CMS through comprehensive clinical evaluation including nasal endoscopy and CT imaging (Evidence: Strong 13).
  • Initiate medical management with antibiotics, nasal corticosteroids, and decongestants for persistent symptoms (Evidence: Moderate 14).
  • Consider endoscopic sinus surgery for refractory cases with anatomical obstructions (Evidence: Moderate 13).
  • Evaluate and address dental origins in unilateral CMS cases (Evidence: Moderate 1).
  • Monitor for complications such as orbital or intracranial involvement in severe cases (Evidence: Expert opinion).
  • Implement long-term follow-up to manage recurrence and chronic symptoms (Evidence: Moderate 14).
  • Refer complex cases to rhinosurgical specialists for advanced interventions (Evidence: Expert opinion).
  • Consider patient-specific factors like age and comorbidities in tailoring treatment plans (Evidence: Moderate 1).
  • Utilize balloon sinuplasty for select patients with anatomical limitations (Evidence: Moderate 3).
  • Educate patients on recognizing signs of complications and the importance of adherence to treatment (Evidence: Expert opinion).
  • References

    1 Pesis M, Kordeluk S, Givol N. Simultaneous management of chronic maxillary sinusitis from dental origin and the relevance of nasal septal deviation: A retrospective evaluation of 65 cases. American journal of otolaryngology 2024. link 2 Agius AM, Jones NS, Muscat R. Prospective three-year follow up of a cohort study of 240 patients with chronic facial pain. The Journal of laryngology and otology 2014. link 3 Lund V. The evolution of surgery on the maxillary sinus for chronic rhinosinusitis. The Laryngoscope 2002. link 4 Terrier G, Baumann RP, Pidoux JM, Chaux-de-Fonds L. Endoscopic and histopathological observations of chronic maxillary sinusitis. Rhinology 1976. link

    Original source

    1. [1]
    2. [2]
      Prospective three-year follow up of a cohort study of 240 patients with chronic facial pain.Agius AM, Jones NS, Muscat R The Journal of laryngology and otology (2014)
    3. [3]
    4. [4]
      Endoscopic and histopathological observations of chronic maxillary sinusitis.Terrier G, Baumann RP, Pidoux JM, Chaux-de-Fonds L Rhinology (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG